04/04/2025
5:09 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
6:30 AM | Anebulo Pharmaceuticals (Filer)
| Form ARS | |
03/06/2025
6:00 AM | Anebulo Pharmaceuticals (Filer)
| Form DEF 14A | |
03/02/2025
11:15 PM | Anebulo Pharmaceuticals (Filer)
| Form EFFECT | |
02/27/2025
6:41 AM | Anebulo Pharmaceuticals (Subject)
English Aron R. (Filed by)
| Form SCHEDULE 13D/A | |
02/24/2025
4:18 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
4:21 PM | Anebulo Pharmaceuticals (Filer)
| Form PRE 14A | |
02/20/2025
4:23 PM | Anebulo Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/14/2025
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/14/2025
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
6:00 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ANEB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/30/2024
5:38 PM | Anebulo Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/26/2024
8:42 PM | Anebulo Pharmaceuticals (Subject)
English Aron R. (Filed by)
| Form SCHEDULE 13D/A | |
12/26/2024
3:15 PM | 22NW Fund, LP (Reporting)
Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:56 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:00 AM | Anebulo Pharmaceuticals (Issuer)
Cunningham, Richard Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
6:00 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/25/2024
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
6:05 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Aryeh Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
SHAH BIMAL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Lawler Joseph F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Kupchyk Areta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Calloway Nathaniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Lin Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
